Neurocrine presents two-year data on CAH treatment Crenessity
Corroborated by 2 sources from 2 publishers
globalhealth3d ago
TL;DR
Neurocrine Biosciences (NBIX) Announces First Presentation of New Two-Year Data From Phase 3 CAHtalyst® Adult Study Neurocrine Biosciences, Inc.